BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10065507)

  • 1. [Photosensitization caused by 5-fluorouracil (5-FU)].
    von Moos R; Sauter C
    Schweiz Med Wochenschr; 1999 Jan; 129(1-2):52. PubMed ID: 10065507
    [No Abstract]   [Full Text] [Related]  

  • 2. Lichenoid photosensitive eruption due to capecitabine chemotherapy for metastatic breast cancer.
    Hague JS; Ilchyshyn A
    Clin Exp Dermatol; 2007 Jan; 32(1):102-3. PubMed ID: 16879449
    [No Abstract]   [Full Text] [Related]  

  • 3. Photosensitive lichenoid drug eruption to capecitabine.
    Walker G; Lane N; Parekh P
    J Am Acad Dermatol; 2014 Aug; 71(2):e52-3. PubMed ID: 25037814
    [No Abstract]   [Full Text] [Related]  

  • 4. Atypical moles in a patient undergoing chemotherapy with oral 5-fluorouracil prodrug.
    Fukushima S; Hatta N
    Br J Dermatol; 2004 Sep; 151(3):698-700. PubMed ID: 15377362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute heart failure after treatment with 5-fluorouracil.
    Georgieva S; Kinova E; Iordanov V; Gudev A; Tzekova V; Velikova M
    J BUON; 2007; 12(1):113-6. PubMed ID: 17436411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of late-onset severe cardiotoxicity from 5-fluorouracil therapy resulting in death.
    Wijesinghe N
    N Z Med J; 2007 Nov; 120(1266):U2836. PubMed ID: 18264205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-SSA/Ro antibody as a risk factor for fluorouracil-induced drug eruptions showing acral erythema and discoid-lupus-erythematosus-like lesions.
    Adachi A; Nagai H; Horikawa T
    Dermatology; 2007; 214(1):85-8. PubMed ID: 17191054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inflammatory effect of systemic fluorouracil in actinic keratosis.
    Nabai H; Mohindra R; Mehregan D
    Cutis; 1999 Jul; 64(1):43-4. PubMed ID: 10431671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon.
    Czito BG; Hong TJ; Cohen DP; Tyler DS; Lee CG; Anscher MS; Ludwig KA; Seigler HF; Mantyh C; Morse MA; Lockhart AC; Petros WP; Honeycutt W; Spector NL; Ertel PJ; Mangum SG; Hurwitz HI
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):779-85. PubMed ID: 14967434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalized pustular drug eruption caused by topical 5-fluorouracil.
    Nemer KM; Solus JF; Schaffer A; Rosman IS; Lee SJ
    Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28834062
    [No Abstract]   [Full Text] [Related]  

  • 11. Vasospastic angina caused by 5-fluorouracil. A case report.
    Pop C; Nica R; Vlaicu R; Vinereanu D
    Rom J Intern Med; 2003; 41(4):433-7. PubMed ID: 15526525
    [No Abstract]   [Full Text] [Related]  

  • 12. Photosensitivity from oral administration of a fluorouracil derivative (FT 207).
    Sun CC; Hsu SC
    Photodermatol; 1984 Apr; 1(2):94-5. PubMed ID: 6442417
    [No Abstract]   [Full Text] [Related]  

  • 13. Healing of colon anastomoses covered with fibrin glue after immediate postoperative intraperitoneal administration of 5-fluorouracil.
    Kanellos I; Mantzoros I; Demetriades H; Kalfadis S; Kelpis T; Sakkas L; Betsis D
    Dis Colon Rectum; 2004 Apr; 47(4):510-5. PubMed ID: 14978614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous side-effects caused by Tegafur.
    Revenga F
    Int J Dermatol; 1999 Dec; 38(12):955-7. PubMed ID: 10671104
    [No Abstract]   [Full Text] [Related]  

  • 15. Paraneoplastic dermatomyositis triggered and exacerbated by oral 5-fluorouracil administration.
    Kawachi Y; Koike Y; Kano T; Furuta J; Fujisawa Y; Nakamura Y; Ishii Y; Takahashi T; Otsuka F
    Eur J Dermatol; 2008; 18(2):195-6. PubMed ID: 18424388
    [No Abstract]   [Full Text] [Related]  

  • 16. [Coronary vasospasm during 5-fluorouracil chemotherapy].
    Sucker C; Scheffold N
    Dtsch Med Wochenschr; 2001 Nov; 126(46):1300-1. PubMed ID: 11709733
    [No Abstract]   [Full Text] [Related]  

  • 17. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute encephalopathy attributed to 5-FU.
    Langer CJ; Hageboutros A; Kloth DD; Roby D; Shaer AH
    Pharmacotherapy; 1996; 16(2):311-3. PubMed ID: 8820478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of an adverse reaction to topical 5-fluorouracil in irradiated skin.
    Lambert T; Mullinax K; Smith J
    J Drugs Dermatol; 2006 Mar; 5(3):282-3. PubMed ID: 16573264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral signs of intravenous chemotherapy with 5-Fluorouracil and Leucovorin calcium in colon cancer treatment.
    Mazzeo MA; Linares JA; Campos ML; Busamia BE; Dubersarsky C; Lavarda M; Jarchum G; Finkelberg AB
    Med Oral Patol Oral Cir Bucal; 2009 Mar; 14(3):E108-13. PubMed ID: 19242388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.